230 related articles for article (PubMed ID: 15629362)
1. Isolation of integral membrane proteins of Leishmania promastigotes and evaluation of their prophylactic potential in hamsters against experimental visceral leishmaniasis.
Garg R; Srivastava JK; Pal A; Naik S; Dube A
Vaccine; 2005 Jan; 23(9):1189-96. PubMed ID: 15629362
[TBL] [Abstract][Full Text] [Related]
2. Serodiagnostic and immunoprophylactic potential of a 78kDa protein of Leishmania donovani of Indian origin.
Mukherjee M; Bhattacharyya A; Duttagupta S
Med Sci Monit; 2002 Apr; 8(4):BR117-22. PubMed ID: 11951057
[TBL] [Abstract][Full Text] [Related]
3. Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis.
Garg R; Gupta SK; Tripathi P; Hajela K; Sundar S; Naik S; Dube A
Vaccine; 2006 Apr; 24(15):2900-9. PubMed ID: 16448729
[TBL] [Abstract][Full Text] [Related]
4. Immunostimulatory cellular responses of cured Leishmania-infected patients and hamsters against the integral membrane proteins and non-membranous soluble proteins of a recent clinical isolate of Leishmania donovani.
Garg R; Gupta SK; Tripathi P; Naik S; Sundar S; Dube A
Clin Exp Immunol; 2005 Apr; 140(1):149-56. PubMed ID: 15762886
[TBL] [Abstract][Full Text] [Related]
5. Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-type immunoprotective response against experimental visceral leishmaniasis.
Samant M; Gupta R; Kumari S; Misra P; Khare P; Kushawaha PK; Sahasrabuddhe AA; Dube A
J Immunol; 2009 Jul; 183(1):470-9. PubMed ID: 19542458
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S
Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
[TBL] [Abstract][Full Text] [Related]
7. Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasis.
Kumari S; Samant M; Misra P; Khare P; Sisodia B; Shasany AK; Dube A
Vaccine; 2008 Oct; 26(45):5700-11. PubMed ID: 18762224
[TBL] [Abstract][Full Text] [Related]
8. The FML-vaccine (Leishmune) against canine visceral leishmaniasis: a transmission blocking vaccine.
Saraiva EM; de Figueiredo Barbosa A; Santos FN; Borja-Cabrera GP; Nico D; Souza LO; de Oliveira Mendes-Aguiar C; de Souza EP; Fampa P; Parra LE; Menz I; Dias JG; de Oliveira SM; Palatnik-de-Sousa CB
Vaccine; 2006 Mar; 24(13):2423-31. PubMed ID: 16386824
[TBL] [Abstract][Full Text] [Related]
9. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes.
Lemesre JL; Holzmuller P; Cavaleyra M; Gonçalves RB; Hottin G; Papierok G
Vaccine; 2005 Apr; 23(22):2825-40. PubMed ID: 15780731
[TBL] [Abstract][Full Text] [Related]
10. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with a novel recombinant Leishmania antigen plus MPL provides partial protection against L. donovani challenge in experimental model of visceral leishmaniasis.
Bhardwaj S; Vasishta RK; Arora SK
Exp Parasitol; 2009 Jan; 121(1):29-37. PubMed ID: 18983842
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Leishmania donovani ribosomal P1 gene as DNA vaccine in experimental visceral leishmaniasis.
Masih S; Arora SK; Vasishta RK
Exp Parasitol; 2011 Sep; 129(1):55-64. PubMed ID: 21640106
[TBL] [Abstract][Full Text] [Related]
13. Induction of Th1-type cellular responses in cured/exposed Leishmania-infected patients and hamsters against polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa.
Kumari S; Samant M; Khare P; Sundar S; Sinha S; Dube A
Vaccine; 2008 Sep; 26(37):4813-8. PubMed ID: 18656517
[TBL] [Abstract][Full Text] [Related]
14. Leishmania donovani: identification of novel vaccine candidates using human reactive sera and cell lines.
Arora SK; Pal NS; Mujtaba S
Exp Parasitol; 2005 Mar; 109(3):163-70. PubMed ID: 15713447
[TBL] [Abstract][Full Text] [Related]
15. Serological evaluation of experimentally infected dogs by LicTXNPx-ELISA and amastigote-flow cytometry.
Silvestre R; Santarém N; Cunha J; Cardoso L; Nieto J; Carrillo E; Moreno J; Cordeiro-da-Silva A
Vet Parasitol; 2008 Nov; 158(1-2):23-30. PubMed ID: 18848397
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of entry of virulent and avirulent strains of Leishmania donovani into macrophages: a possible role of virulence molecules (gp63 and LPG).
Chakrabarty R; Mukherjee S; Lu HG; McGwire BS; Chang KP; Basu MK
J Parasitol; 1996 Aug; 82(4):632-5. PubMed ID: 8691373
[TBL] [Abstract][Full Text] [Related]
17. Non PC liposome entrapped promastigote antigens elicit parasite specific CD8+ and CD4+ T-cell immune response and protect hamsters against visceral leishmaniasis.
Sharma SK; Dube A; Nadeem A; Khan S; Saleem I; Garg R; Mohammad O
Vaccine; 2006 Mar; 24(11):1800-10. PubMed ID: 16310900
[TBL] [Abstract][Full Text] [Related]
18. Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs.
Nogueira FS; Moreira MA; Borja-Cabrera GP; Santos FN; Menz I; Parra LE; Xu Z; Chu HJ; Palatnik-de-Sousa CB; Luvizotto MC
Vaccine; 2005 Sep; 23(40):4805-10. PubMed ID: 16011864
[TBL] [Abstract][Full Text] [Related]
19. Protective immunogenicity of the paraflagellar rod protein 2 of Leishmania mexicana.
Saravia NG; Hazbón MH; Osorio Y; Valderrama L; Walker J; Santrich C; Cortázar T; Lebowitz JH; Travi BL
Vaccine; 2005 Jan; 23(8):984-95. PubMed ID: 15620471
[TBL] [Abstract][Full Text] [Related]
20. Domestic swine in a visceral leishmaniasis endemic area produce antibodies against multiple Leishmania infantum antigens but apparently resist to L. infantum infection.
Moraes-Silva E; Antunes FR; Rodrigues MS; da Silva Julião F; Dias-Lima AG; Lemos-de-Sousa V; de Alcantara AC; Reis EA; Nakatani M; Badaró R; Reis MG; Pontes-de-Carvalho L; Franke CR
Acta Trop; 2006 May; 98(2):176-82. PubMed ID: 16730628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
